US ice cream makers say they'll stop using artificial dyes by 2028
:
About 40 makers of ice cream and frozen dairy desserts said they would remove seven petroleum-based dyes from their products by 2028, according to Michael Dykes, president of the International Dairy Foods Association. The colors are Red 3, Red 40, Green 3, Blue 1, Blue 2, Yellow 5 and Yellow 6. The trade group wouldn't identify the firms, although Turkey Hill Dairy chief executive Andy Jacobs joined the gathering.
The national focus on artificial food dyes is 'a good step to take,' but officials should not ignore larger known contributors to chronic disease, including the added sugars and saturated fat commonly found in ice cream, said Deanna Hoelscher, a University of Texas nutrition expert.
Advertisement
'Just taking out or changing the food dye source is not necessarily going to make it a healthy option,' she said. 'It still is a food that should be consumed in moderation.'
However, Makary also hinted that new federal dietary guidelines, expected later this year, would challenge established links between saturated fat and heart disease, ending what he called 'a 70-year demonization of natural saturated fat.'
Advertisement
The average American eats about 4 gallons of ice cream a year, the IDFA said.
Health advocates have long called for the removal of artificial dyes from foods, citing mixed studies showing that they may cause some neurobehavioral problems, such as hyperactivity and attention problems, in some children. The Food and Drug Administration has maintained that approved dyes are safe and that 'most children have no adverse effects' when consuming foods made with them.
Health Secretary Robert F. Kennedy Jr.
The FDA has approved new natural color additives in recent months, including a new blue color made from the fruit of the gardenia announced Monday. Gardenia (genipin) blue is approved for use in sports drinks, candies and certain other products, the agency said.
Makary also sent a letter to food manufacturers on Monday that 'encourages' them to speed up removal of the dye known as Red 3, which was
Related
:
Some food companies have said they will stop using artificial dyes, but relying on voluntary action rather than regulatory requirements won't guarantee compliance, said Thomas Galligan, a scientist with the Center for Science in the Public Interest, a consumer advocacy group.
Advertisement
'Talk is cheap,' Galligan said. 'It's easy for companies to make promises to look like they're being compliant and generate goodwill among consumers and the Trump administration, but it remains to be seen if they will actually follow through.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Scar tissue in athletes hearts tied to higher risk of dangerous cardiac rhythms
Research Highlights: Scar tissue in the heart may be linked to dangerous heart rhythms in otherwise healthy athletes, according to a U.K. study. The study, VENTOUX, named after Mont Ventouxone of the most gruelling climbs in the world-renowned Tour de France cycling raceincluded about 100 male cyclists and triathletes over age 50. Embargoed until 6:01 p.m. CT/7:01 p.m. ET, Thursday, July 17, 2025 (NewMediaWire) - July 17, 2025 - DALLAS Scar tissue in the heart was associated with abnormal heart rhythms among healthy, long-time male endurance athletes age 50 or older, potentially increasing their risk of sudden cardiac death, according to a small study published today in Circulation:Cardiovascular Imaging, an American Heart Association journal. An irregular rhythm originating from a ventricular heart chamber, called ventricular tachycardia, is considered one of the most serious types of abnormal heart rhythm. It is extremely dangerous and can lead to sudden cardiac death. Sudden cardiac arrest is a leading cause of death in athletes, mostly affecting older men. Myocardial fibrosisthe scarring or thickening of heart muscle tissuehas previously been linked to irregular heartbeats; however, how it affects otherwise healthy endurance athletes remains unclear. "Dangerous heart rhythms during sport are thankfully rare," said senior study author Peter Swoboda, M.B.B.S., Ph.D., an associate professor of cardiology at the University of Leeds in the U.K. "In certain highly trained athletesparticularly as they get olderit is possible to identify scarred heart tissue via magnetic resonance imaging. We wanted to investigate whether dangerous heart rhythms in endurance athletes might be caused by heart scarring. "Our main aim was to help endurance athletes continue to participate safely in sports, particularly as they get older," he said. The study called VENTOUX was named after a famous mountain climb in the world-renowned Tour de France bike race. The researchers followed 106 male cyclists/triathletes aged 50 or older, who had no symptoms of heart disease. All had trained at least 10 hours a week for 15 years or more. The participants underwent cardiovascular magnetic resonance (CMR) imaging, a specialized test that uses magnetic fields to produce detailed images of the heart. They also had an ECG recorder implanted under the skin of their chest that recorded every heartbeat for two years. During an average follow-up of two years, researchers found: almost half of the athletes (47.2%) showed signs of scarring on the left ventricle of the heart; and about 3% of the athletes had sustained, potentially dangerous fast heart rate originating in the lower chambers of the heart, while 19% experienced shorter bursts of rapid heartbeats. Any participant who developed a potentially harmful rhythm was contacted urgently to assess symptoms and advised to seek independent medical attention. "We did not expect the association between scarring and dangerous rhythms to be this strong," Swoboda said. "Similar findings have been reported in patients with heart muscle disease, however, we did not expect this in healthy, performance athletes." He urged any athlete who experiences chest pain, dizziness or palpitations during activity to seek treatment and also advised, "It's important that everyone involved in sports knows CPR and how to use an automated external defibrillator." Although the annual incidence of sudden cardiac death during sports varies among studies, the annual rate of abnormal heart rhythms detected in this study were considerably higher than rates among the general population. The study has several limitations such as including a small number of very select participants. The findings may not apply to people not represented in the study: women, non-athletes or non-European cyclists. In addition, the findings could not differentiate whether the cardiac scarring itself was the cause of irregular heart rhythms or if it was a marker for a separate underlying process. Future research will examine women, the authors said. Study details, background and design: The study enrolled 106 athletes from sporting organizations in the U.K. The athletes self-reported their training history, and those with pre-existing heart conditions were excluded. Upon entry into the study, participants underwent clinical assessments, imaging and had a loop recorder implanted. The loop recorder monitored for ventricular arrhythmia for two years. A comparative group of age-matched, male, non-athletes was enrolled to undergo the same imaging. Each participant was asked to continue with their normal daily activities and sporting habits. The study was funded by the British Heart Foundation, the National Institute for Health and Care Research, Leeds Biomedical Research Centre and Leeds Clinical Research Facility. Co-authors, disclosures are listed in the manuscript. Studies published in the American Heart Association's scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content. Overall financial information is available here. Additional Resources: Available multimedia is on right column of release link After 7:01 pm ET on July 17, 2025, view the manuscript online. AHA health information: What is an Arrhythmia? AHA health information: Watch an animation of ventricular fibrillation AHA health information: Cardiac Arrest vs Heart Attack Follow AHA/ASA news on X @HeartNews Follow news from the AHA's Circulation: Cardiovascular Imaging journal @CircImaging ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173 Bridgette McNeill: For Public Inquiries: 1-800-AHA-USA1 (242-8721) and
Fast Company
6 hours ago
- Fast Company
The next frontier for precision medicine: Pediatricians
Many families now have a new reality when they visit their pediatrician's office. Instead of leaving with more questions, they have answers and a real plan. Genomic testing, once reserved for rare or complex cases and ordered by specialists, is rapidly becoming a standard tool in pediatric care. The latest guidance from the American Academy of Pediatrics (AAP), released this year, recommends using exome and genome sequencing as a first-tier test for more children, particularly those with developmental delays and intellectual disabilities. More than one in three children with developmental delays, intellectual disabilities, or autism have an underlying genetic condition that can be found using genetic testing. Given known genetic links to autism, pediatricians can now genomic insights right from the start, moving forward bringing answers and actionable next steps in a child's care journey. This shift is transforming how we diagnose, treat, and support kids with unexplained medical challenges. Invest in science Spun out of the National Institutes of Health (NIH), GeneDx was founded 25 years ago on the belief that genomic science could fundamentally change how we diagnose and treat disease. At the time, this field felt like the frontier, a promising but distant future, more exploration than clinical applications. Today, that vision is a reality. GeneDx has discovered more than 500 links between specific genes and diseases. What once felt futuristic is now central to modern pediatric care. Genomic testing has become faster, more affordable, and more accessible. The updated AAP guidance means genomic testing should be integrated into every family's pediatric office. It should be used to diagnose rare diseases and understand the genetic cause of common conditions like autism and epilepsy with greater speed and precision. It's not just about understanding the root cause, it's about accelerating the path to accurate treatment that can change or save children's lives. This transformation didn't happen overnight. It was the result of decades of scientific investment—our collective bet on the future of healthcare—to one day ensure children live longer and healthier lives. That investment paid off. Genomic testing not only improves outcomes for patients and families, but it also reduces overall healthcare costs through fewer unnecessary tests and procedures, earlier diagnoses, and more targeted interventions and treatments. Continued investments in science and medicine are essential. Advancing access to genomic testing isn't just about what's possible today, it's about building a healthcare system that's smarter, more sustainable, and truly patient-centered. Why genomic testing matters What was once only available to few, is now broadly available. Genomic testing offers immediate and profound benefits for families. For children facing developmental delays or other unexplained health issues, a single test can sometimes reveal the underlying cause in weeks or even days, in critical situations. This means families no longer must endure months or sometimes years of uncertainty—with multiple rounds of inconclusive tests, uninformative specialist visits, or unnecessary medical bills and suffering. Instead, clear answers can arrive quickly, allowing everyone to move forward with personalized treatment plans in confidence. With a genetic diagnosis in hand, doctors can provide truly targeted care, tailoring treatments, therapies, and support to fit the unique needs for a diagnosis and in some cases, even stop disease progression. A confirmed diagnosis also opens doors to early intervention, specialized care teams, clinical trials, and support networks that might otherwise remain out of reach. Exome and genome testing are transforming the path to answers and support for children and their families, and now it's more accessible than ever before. Looking ahead We see the AAP's guidance as a major milestone, bringing genomics into everyday pediatric care. And for the first time, genomics is equipping pediatricians with critical insights to support early diagnosis and intervention. But this is just the beginning. We're still in the early chapters of what genomic science and care can unlock. To fully realize its potential, we must continue investing in innovation and driving progress that elevates the standard of care across every clinical setting. Where a child accesses care should never determine their outcome. Today, we see genomic insights shaping the future in pediatricians' offices. Tomorrow, we envision a world where every baby's genome is sequenced at birth, giving families the power to stop disease before symptoms even start. My career has been dedicated to expanding access to genomic testing, and I commend the AAP for helping pave the way toward a new standard of care, one where genomics plays a central role in improving pediatric health outcomes nationwide. The path to answers—and to hope—has never been more accessible. Bringing genomics into the hands of every pediatrician marks a critical step toward shortening the diagnostic journey for families, enabling earlier intervention, and reducing costs for both patients and the healthcare system. It's a meaningful advancement in pediatric care, and one that brings us closer to a future where children can be diagnosed before symptoms even begin.
The Hill
8 hours ago
- The Hill
Democratic AGs sue Trump administration to block ObamaCare changes
A coalition of 20 Democratic attorneys general sued the Trump administration Thursday to block implementation of a rule they argue will undermine the Affordable Care Act. The complaint was co-led by California, Massachusetts and New Jersey and filed in federal court in Massachusetts. The lawsuit alleges that the Department of Health and Human Services illegally made changes to the health law, which will make it harder for people to enroll and shift costs to states. The final rule, issued in June, would make numerous amendments to regulations governing federal and state health insurance marketplaces, which the administration estimates will cause almost 2 million people to lose their health insurance. The attorneys general are asking the court to block portions of the rule from taking effect next month. According to the lawsuit, the rule 'truncates and eliminates enrollment periods, makes enrollment more difficult, adds eligibility verification requirements, and erects unreasonable barriers to coverage—making sweeping changes that reach far beyond and bear little relation to the primary harm HHS asserted as its justification: fraudulent enrollment by insurance brokers and agents.' The rule also excludes coverage of gender-affirming care as an essential health benefit. 'Far from delivering on their promises to drive down costs and 'make America healthier' the Trump Administration's HHS and CMS are doing their best to make it harder and more expensive for Americans to obtain health insurance and access care,' California Attorney General Bonta said in a statement. In the lawsuit, the attorneys general argue that the rule is unlawful, arbitrary and capricious, and would cause significant harm to states and their residents. All of the challenged marketplace changes implemented by the final rule will be harmful to individual consumers and state and local governments, the lawsuit claims. According to the Department of Health and Human Services, the final rule is meant to limit improper enrollments and the improper flow of federal funds. The rule is projected to save up to $12 billion in 2026 by 'reining in wasteful federal spending, and refocusing on making health insurance markets more affordable and sustainable for hardworking American families.'
